ARIES System
by Luminex Corporation 2 variants
510(k) K160517
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK160517 | Date12 Apr 2016 | StatusActive |
Official records
- FDA 510(k) database K160517
From the FDA record
- Received by the FDA
- 24 Feb 2016
- FDA decision
- 12 Apr 2016 (Substantially Equivalent)
- FDA review time
- 48 days from receipt to decision
- Public document
- 510(k) statement on file with the FDA
Recalls
-
- Ongoing Z-2288-2019
Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.
-
- Terminated Z-2292-2019
An incorrect control board and firmware installed in some of the Hand Held Barcode Scanners could result in sample/patient mismatch or duplicate results (from other patients specimens) for a patient order.
-
- Terminated Z-2094-2017
The hand-held barcode scanner that is used as an accessory to enter ARIES cassette and specimen identifications on the ARIES Systems populates patient sample IDs with a previously scanned sample ID when entering orders into an ARIES instrument.
Timeline
- Cleared FDA 510(k) K160517
- Recall initiated FDA recalls Z-2094-2017
- Recall initiated FDA recalls Z-2292-2019
- Recall initiated FDA recalls Z-2288-2019
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- OOI
- Device class
- Class II
- Regulation
- 21 CFR Part 862.2570
- Advisory committee
- Clinical Chemistry
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Aries System is a Real-Time Nucleic Acid Amplification System, designed for molecular diagnostics in clinical chemistry. It automates nucleic acid extraction, real-time PCR amplification, and signal detection for multiplex assays, enabling simultaneous analysis of multiple targets from various sample types.
This system is intended for use in clinical laboratory settings and is supplied as a reusable device. It operates under sterile conditions for nucleic acid processing and detection, with no specific MRI safety restrictions noted. The system supports multiple assay configurations, as indicated by its regulatory registration numbers, and holds FDA 510(k) clearance under Special Review (K160517). Sterility and maintenance protocols are manufacturer-defined, with no explicit single-use designation.
Devices cleared under K160517
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| ARIES® Extraction Kit 50-10026 | 50-10026 | 00840487100073 | No longer on the market | |
| SYNCT™ Software CN-SW47 | CN-SW47 | 00840487100448 | On the market |
Similar devices
Other devices filed under FDA product code OOI (Real Time Nucleic Acid Amplification System).
- BD MAX™ Enteric Bacterial Panel 442963 by Becton, Dickinson and Company
- Alinity m 09N26-014 by Abbott Molecular
- Panther Fusion® PARAFLU KIT, PANTHER FUSION, 96T, IVD PRD-04329 by Hologic
- BD MAX™ Enteric Parasite Panel 442960 by Becton, Dickinson and Company
- Exicycler™ V5 384 A-2065-3 by Bioneer Corporation
- Alinity m 09N20-002 by Abbott Molecular
- 3M Integrated Cycler (110V) & (220V) by Focus Diagnostics, Inc.
- Simplexa COVID-19 / Flu A/B & RSV Positive Control Pack MOL4460 by DiaSorin Molecular LLC
- Alere i Instrument, Alere i Influenza A & B, Alere i Strep A by Alere Scarborough, Inc.
- NUCLISENS EASYQ ENTEROVIRUS V1.1., NUCLISENS EASYQ DIRECTOR 2.6, NUCLISENS EASYQ ANALYZER, NUCLISENS MINIMAG by BIOMERIEUX, INC.